Global Icosapent Ethyl API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Icosapent Ethyl API market size was valued at US$ 242 million in 2024 and is forecast to a readjusted size of USD 397 million by 2031 with a CAGR of 7.3% during review period.
Eicosapentaenoic Acid Ethyl Ester (EPA-EE) API is a highly purified fatty acid ethyl ester compound, the core component of which is the ethyl ester form of eicosapentaenoic acid (EPA). As an important member of the Omega-3 fatty acid family, EPA-EE is widely used in the fields of medicine and health care products, mainly due to its unique biological activity and health benefits. EPA-EE usually appears as a colorless to light yellow transparent liquid with a slight special odor. EPA is mainly found in the oils of deep-sea fish (such as sardines, mackerel, and salmon) and is obtained by extraction and purification.
There are more than 500 million patients with cardiovascular disease (CVD) worldwide. EPA-EE, as a high-purity ω-3 fatty acid, has been proven by multiple studies (such as the REDUCE-IT trial) to reduce the risk of cardiovascular events by 25%-30%. Therefore, it is widely used. The US FDA approved Vascepa (containing EPA-EE) for lowering triglyceride levels, and the EU included high-purity ω-3 preparations in the category of prescription drugs. The Asia-Pacific region (especially China and Japan) uses EPA-EE for functional foods, driving the growth of over-the-counter demand.
This report is a detailed and comprehensive analysis for global Icosapent Ethyl API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Icosapent Ethyl API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Icosapent Ethyl API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Icosapent Ethyl API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Icosapent Ethyl API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Icosapent Ethyl API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Icosapent Ethyl API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chemport Inc, Dsm Nutritional Products Ltd, Ak Biopharm Co Ltd, Huatai Pharma Inc, Bizen Chemical Co Ltd, Finorga Sas, Sichuan Gowell Pharmaceutical Co Ltd, Axplora, SimSon Pharma Limited, CCSB, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Icosapent Ethyl API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥90%
Purity<90%
Market segment by Application
Drugs
Health Care Products
Others
Major players covered
Chemport Inc
Dsm Nutritional Products Ltd
Ak Biopharm Co Ltd
Huatai Pharma Inc
Bizen Chemical Co Ltd
Finorga Sas
Sichuan Gowell Pharmaceutical Co Ltd
Axplora
SimSon Pharma Limited
CCSB
BASF
Novasep
KD Pharma
Nissui
Nisshin Seifun
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Icosapent Ethyl API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Icosapent Ethyl API, with price, sales quantity, revenue, and global market share of Icosapent Ethyl API from 2020 to 2025.
Chapter 3, the Icosapent Ethyl API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Icosapent Ethyl API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Icosapent Ethyl API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Icosapent Ethyl API.
Chapter 14 and 15, to describe Icosapent Ethyl API sales channel, distributors, customers, research findings and conclusion.
Eicosapentaenoic Acid Ethyl Ester (EPA-EE) API is a highly purified fatty acid ethyl ester compound, the core component of which is the ethyl ester form of eicosapentaenoic acid (EPA). As an important member of the Omega-3 fatty acid family, EPA-EE is widely used in the fields of medicine and health care products, mainly due to its unique biological activity and health benefits. EPA-EE usually appears as a colorless to light yellow transparent liquid with a slight special odor. EPA is mainly found in the oils of deep-sea fish (such as sardines, mackerel, and salmon) and is obtained by extraction and purification.
There are more than 500 million patients with cardiovascular disease (CVD) worldwide. EPA-EE, as a high-purity ω-3 fatty acid, has been proven by multiple studies (such as the REDUCE-IT trial) to reduce the risk of cardiovascular events by 25%-30%. Therefore, it is widely used. The US FDA approved Vascepa (containing EPA-EE) for lowering triglyceride levels, and the EU included high-purity ω-3 preparations in the category of prescription drugs. The Asia-Pacific region (especially China and Japan) uses EPA-EE for functional foods, driving the growth of over-the-counter demand.
This report is a detailed and comprehensive analysis for global Icosapent Ethyl API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Icosapent Ethyl API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Icosapent Ethyl API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Icosapent Ethyl API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Icosapent Ethyl API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Icosapent Ethyl API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Icosapent Ethyl API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chemport Inc, Dsm Nutritional Products Ltd, Ak Biopharm Co Ltd, Huatai Pharma Inc, Bizen Chemical Co Ltd, Finorga Sas, Sichuan Gowell Pharmaceutical Co Ltd, Axplora, SimSon Pharma Limited, CCSB, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Icosapent Ethyl API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥90%
Purity<90%
Market segment by Application
Drugs
Health Care Products
Others
Major players covered
Chemport Inc
Dsm Nutritional Products Ltd
Ak Biopharm Co Ltd
Huatai Pharma Inc
Bizen Chemical Co Ltd
Finorga Sas
Sichuan Gowell Pharmaceutical Co Ltd
Axplora
SimSon Pharma Limited
CCSB
BASF
Novasep
KD Pharma
Nissui
Nisshin Seifun
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Icosapent Ethyl API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Icosapent Ethyl API, with price, sales quantity, revenue, and global market share of Icosapent Ethyl API from 2020 to 2025.
Chapter 3, the Icosapent Ethyl API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Icosapent Ethyl API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Icosapent Ethyl API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Icosapent Ethyl API.
Chapter 14 and 15, to describe Icosapent Ethyl API sales channel, distributors, customers, research findings and conclusion.
Table of Contents
121 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Icosapent Ethyl API by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
